摘要
目的探讨甘肃地区人群雌激素受体(ER)α-29位多态性与HBV感染相关原发性肝癌(PHC)发生的关系,从基因水平上探讨PHC的发病机制。方法采用聚合酶链反应-限制性片段长度多态性法检测106例HBV感染相关PHC患者、98例健康对照人群的ERα-29位多态性。用基因计数法计算检验人群的等位基因频率,进行Hardy-Weinberg遗传平衡定律检验。基因型及等位基因频率比较采用χ^2检验。结果 HBV感染相关PHC患者ERα-29位多态性的TT基因型和T等位基因频率(31.1%,53.8%)明显高于对照组(11.2%,32.1%),差异有统计学意义(χ^2值分别为3.449、3.840,P值均〈0.05);CC基因型和C等位基因频率(23.6%,46.2%)明显低于后者(47.0%,67.9%),差异有统计学意义(χ^2值分别为3.488、3.840,P值均〈0.05);T等位基因发生HBV感染相关PHC的风险是C等位基因的2.46倍(OR=2.46,95%CI:1.64~3.69)。结论 ERα-29位T等位基因可增加HBV感染相关肝癌发病的风险。
Objective To evaluate the relationship between estrogen receptor - α - 29 ( ERα - 29) gene polymorphisms and the develop- ment of HBV - related hepatocellular carcinoma (HCC) in Gansu Province, China, and to investigate the pathogenesis of HCC at the gene level. Methods Gene polymorphisms of ERα - 29 were analyzed in 106 HBV - related HCC patients and 98 healthy individuals as normal controls using the polymerase chain reaction -restriction fragment length polymorphism technique. Population allele frequencies were calcu- lated using the gene counting method and then tested using the Hardy - Weinberg law of genetic equilibrium. Comparisons of genotype and allele frequencies between groups were performed using the 22 test. Results The frequencies of Tr genotype and T allele of ERα -29 gene in HBV - related HCC patients were significantly higher than those in the normal controls, i.e. , 31.1% and 53.8% vs. 11.2% and 32.1% (χ^2 = 3. 449, P 〈 0. 05 ; χ^2 = 3. 840, P 〈 0.05). In contrast, the frequencies of CC genotype and C allele of ERα - 29 gene in HBV - related HCC patients were significantly lower than those in the normal controls, i.e. , 23.6% and 46.2% vs. 47.0% and 67.9% (χ^2= 3. 488, P 〈 0. 05 ; χ^2 = 3. 840, P 〈 0. 05 ). Compared with those carrying C allele, carriers of T allele had an increased risk (2.46 - fold) of HBV - relat- ed HCC ( OR = 2. 46, 95% CI: 1.64 - 3.69). Conclusion T allele of ERα- 29 gene can increase the risk of HBV - related HCC.
出处
《临床肝胆病杂志》
CAS
2015年第2期240-243,共4页
Journal of Clinical Hepatology
关键词
肝肿瘤
受体
雌激素
多态性
单核苷酸
多态性
限制性片段长度
liver neoplasms
receptors, estrogen
polymorphisms, single nucleotide
polymorphism, restriction fragment length